Pharma Brexit Brief Quick Facts

Pharma Brexit Brief

What is Pharma Brexit Brief? It is a living source of updated brief key points to watch for the pharmaceutical industry on Brexit, “deal” or “no-deal” resolution. Pharma Brexit Brief is a single source of information to refer to. Brexit´s Key Impact Aspects on Pharmaceutical Industry: Labor: UK is the third largest country in the EU (after Germany and Switzerland) to utilize pharmaceutical R&D funds of pharmaceut
Read More

Sustainable Joint Procurement

At the National level, Cross-border JP and Organizational experience, and why Europe does not lack organizational expertise.
Read More
Parallel Trade of Pharmaceuticals

Restrictions on parallel trade in pharmaceuticals

The article is only available in Bulgarian, read the full article via ResearchGate web site.
Read More